European Archives - Page 725 of 1065 - European Medical Journal

Epstein–Barr Virus: A Biological Overview and Clinicopathological Changes of Two Epstein–Barr Virus-Related Lymphoproliferative Disorders in a World Health Organization (WHO) 2017 Report

Epstein–Barr virus (EBV) is one of the most important viral causes for the development of tumours. The global geographical epidemiology of EBV shows…

A Game of Clones: The Complex Interplay of Aplastic Anaemia, Myelodysplastic Syndrome, and Paroxysmal Nocturnal Haemoglobinuria

Although idiopathic aplastic anaemia (AA), myelodysplastic syndrome (MDS), and paroxysmal nocturnal haemoglobinuria (PNH) are all associated with…

Top 10 selling drugs

This infographic explores the top-performing drugs of 2017, and looks ahead to those that could triumph nearly a decade later. Find out which drugs are predicted to stay on top, and which others could be on their way down.

Beetroot Could Reduce Blood Pressure in Pregnant Women

Pregnant women can reduce their blood pressure by consuming beetroot juice, a study from the University of Manchester, Manchester, UK has suggested…

Long-Term Health Affected by Paternal Diet

A person’s long-term health is directly affected by their father’s diet, a study from the University of Nottingham, Nottingham, UK has shown. The…

TNF Inhibitor Treatment and Cancer Recurrence in Rheumatoid Arthritis

Cancer recurrence after TNF inhibitor (TNFi) treatment in rheumatoid arthritis (RA) patients with a history of solid cancer was no greater than in a…

TNF Inhibitors and Cardiovascular Events

Reduced risk of cardiovascular events has been associated with sustained treatment with biologics or TNF inhibitors in patients with rheumatoid arthritis…

EMJ Reproductive Health 4 [ePrint] 2018

EMJ has released the newest issue of the EMJ Reproductive Health eJournal, which includes a complete review of this year’s…

Fresh Understanding into the Causes of a Form of Heart Failure

Insights into the causes of heart failure with preserved ejection fraction could help identify people at risk of developing the condition early and lead…

ESHRE 2018 - Interview - Prof Klaus Dugi

An interview with Prof Klaus Dugi (Chief Medical Officer and Executive Vice President, Ferring) at this year’s ESHRE Congress held in Barcelona, Spain.